The reagents and solvents used in this study are commercially available. The synthesis of (Z)-5-(3-methylbenzylidene)-2-thioxothiazolidin-4-one was carried out by reported our procedure [1] . A mixture of 3-methylbenzaldehyde (3 mmol, 360 mg), 2-thioxothiazolidin-4-one (3 mmol, 400 mg), and Et 2 NH (3 mmol, 310 μl) in 3ml of degassed H 2 O was stirred at room temperature for 3-5 hours until TLC showed complete disappearance of the reactants. Water (3 ml) was then added into the reaction mixture, then extracted with DCM/EtOH (3´50 ml) and the organic phase washed with 10%HCl (2´50 ml), followed by brine (2´50 ml), and dried overMgSO 4 , and filtered off and evaporated to afford the desired product. 
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The reagents and solvents used in this study are commercially available. The synthesis of (Z)-5-(3-methylbenzylidene)-2-thioxothiazolidin-4-one was carried out by reported our procedure [1] . A mixture of 3-methylbenzaldehyde (3 mmol, 360 mg), 2-thioxothiazolidin-4-one (3 mmol, 400 mg), and Et 2 NH (3 mmol, 310 μl) in 3ml of degassed H 2 O was stirred at room temperature for 3-5 hours until TLC showed complete disappearance of the reactants. Water (3 ml) was then added into the reaction mixture, then extracted with DCM/EtOH (3´50 ml) and the organic phase washed with 10%HCl (2´50 ml), followed by brine (2´50 ml), and dried overMgSO 4 , and filtered off and evaporated to afford the desired product. 
Discussion
The rhodanine (2-thioxothiazolidin-4-one) ring system is a core structure in various synthetic pharmaceuticals displaying diverse pharmacological properties such as antiinflammatory, antiviral, anti-proliferative, anticonvulsant, anti-diabetic, anti-tubercular, cardiovascular, anti-hyperlipidemic, antifungal and antibacterial, properties. Several such derivatives as etozoline (antihypertensive), pioglitazone (hypoglycemic), ralitoline (anticonvulsant), and thiazolidomycin (activity against Streptomyces species), based on this pharmacophore are already on the market [1] [2] [3] [4] [5] [6] . The title structure is composed of a planar thioxothiazolidin-4-one ring (C1/N1/C2/C3-S2) having a 3-methylbenzylidene substituent (C4/C5-C10) attached to C3. The dihedral angle between these two planes is 2.37(2)°. The methyl group C11 is disordered over two positions with an occupancy ratio of 0.67:0.33. The asymmetrical unit involves a dimethtyl sulphoxide (DMSO) solvate molecule ( Fig.) which plays an important role in the stabilization of the crystal structure. 
